Jakarta, July 21, 2020, PT Kalbe Farma Tbk (Kalbe) in collaboration with APINDO (Indonesian Employers Association) and Apindo Training Center (PT Pusat Studi Apindo) supported by the government through the BPJS Ketenagakerjaan (Employment) & BPJS Kesehatan (Healthcare), held an Industrial Relations Innovation Insight educational webinar with the theme "Updated Covid-19 Variants & Vaccination, and K3 Management Control during the Implementation of Emergency PPKM" with speakers: dr. Muhammad Syahril Mansyur Sp.P, MPH - President Director of RSPI Sulianti Saroso, Jakarta & Interim President Director of RS Persahabatan, Jakarta;  dr. Esther Kristiningrum – Senior Medical Manager of PT Kalbe Farma Tbk.; dr. Rima Melati, MKK, SpAk, SpOk  – Member of the K3 Committee of Apindo ; Iftida Yasar, S.H., M.Psi - Supervisory Board of BPJS Kesehatan; and Subchan Gatot - Supervisory Board of BPJS Ketenagakerjaan; with moderator Dr.  Soeprayitno, MBA.,MSc. – Director of PT. Pusat Studi Apindo (ATC).

Jakarta, July 9, 2021. PT Kalbe Farma Tbk (“Kalbe”) has received approval from the Food and Drug Supervisory Agency (“BPOM”) to conduct a phase 2b/3 clinical trial for the COVID-19 GX-19N vaccine in Indonesia. The clinical trial phase 2b/3 will start recruitment in July 2021 and is expected to have enough data to carry out an interim analysis for safety and efficacy (the ability of the vaccine to trigger immunity against COVID-19 infection) by end of 2021.

Jakarta, July 5, 2021, PT Kalbe Farma Tbk (Kalbe).  The increase in positive cases of COVID-19 in various regions in Indonesia has encouraged the government through the Ministry of Health to strengthen the implementation of 3T, namely Testing, Tracing, and Treatment. Testing, apart from screening, is also very necessary for tracking or tracing so that suspects and close contacts of confirmed cases can be found. Under the circumstances, Kalbe is trying to support the government, especially regional governments, by providing the infrastructure for testing the SARS-CoV-2 virus using the RT-LAMP Saliva examination method. The RT-LAMP method which is a biomolecular examination is categorized as the NAAT (Nucleic Acid Amplification Test) test in which the RT-PCR is of the same category.